Lyell Immunopharma to Brief Investors on CAR-T in November
Investors and cell therapy supply-chain operators can use the November sessions to gauge the company's projected 1,200-dose annual manufacturing capacity.
Updated on Nov. 2, 2026 in Corporate Finance
Lyell Immunopharma, a Nasdaq-listed late-stage clinical company developing next-generation CAR T-cell therapies, will take part in several November 2026 investor events, including a Goldman Sachs RxChange fireside chat on November 5 and a Stifel Healthcare Conference fireside chat on November 10. For investors and healthcare-sector operators tracking cell therapy developers, the schedule is a near-term checkpoint on the company's clinical and manufacturing update.
Why it matters
Investor conference appearances give public companies a scheduled venue to update the market on clinical programs and manufacturing readiness outside of earnings releases. For operators in biotech and healthcare services, the timing matters because CAR T-cell commercialization depends heavily on manufacturing capacity and reimbursement readiness, both of which these events are expected to address.
The company's LyFE Manufacturing Center in South San Francisco is projected to manufacture more than 1,200 CAR T-cell doses per year. The announcement lists three investor appearances across November 5, 10, and 18, 2026, with no comparator figures provided.
The players
Lyell Immunopharma
A late-stage clinical company developing next-generation CAR T-cell therapies, listed on Nasdaq under LYEL and operating its LyFE Manufacturing Center in South San Francisco.
Goldman Sachs
A global investment bank whose RxChange conference series brings healthcare companies together with institutional investors.
Stifel
A financial services firm whose annual Healthcare Conference connects healthcare companies with institutional investors.
Jefferies
A global investment bank whose Global Healthcare Conference hosts one-on-one meetings between healthcare companies and investors.
The details
Lyell is participating through fireside chats and one-on-one meetings rather than formal presentations, a format that typically gives investors direct access to management without a scripted slide deck. The Stifel fireside chat will be webcast live with a replay available on the Investors section of lyell.com. The company also states that its LyFE Manufacturing Center has commercial launch capability, which is the operational foundation for the projected 1,200-dose annual capacity.
Timeline
Thursday, November 5, 2026, at 11:00 am ET: Goldman Sachs RxChange fireside chat on lymphoma CAR-T data.
Tuesday, November 10, 2026, at 4:00 pm ET: Stifel 2026 Healthcare Conference fireside chat and 1x1 meetings.
Wednesday, November 18, 2026: Jefferies Global Healthcare Conference 1x1 meetings.
Market Landscape
Biotech companies routinely schedule fireside chats and one-on-one meetings at the Goldman Sachs, Stifel, and Jefferies healthcare conferences as recurring disclosure points between quarterly reports. Lyell's November slate follows that established calendar pattern, positioning the company's CAR T-cell manufacturing story alongside peers presenting at the same venues.
Operators in biotech supply, contract manufacturing, and healthcare services should note that cell therapy capacity claims are now being made publicly ahead of formal data releases. Procurement and finance teams tracking vendor and partner exposure to CAR T-cell developers should watch whether these investor sessions shift guidance on manufacturing volume.
The takeaway
For operators, the practical signal is the projected 1,200-dose annual manufacturing capacity, which can be compared against future company disclosures on commercial readiness. Calendar the November 10 Stifel webcast and its replay on lyell.com to review management's commentary directly.
What happens next
Lyell's management is scheduled to speak at the Goldman Sachs RxChange fireside chat on November 5, 2026, the Stifel fireside chat on November 10, 2026, and hold Jefferies one-on-one meetings on November 18, 2026.
Further reading
For broader context on how public companies use these scheduled appearances, see Corporate Finance coverage across California's listed firms.
More information
Lyell's investor relations website hosts the Stifel webcast replay and company disclosures.
Source note: This article includes information reported by The Manila times.
